Authors
Loading...
Mixed-methods evaluation identifies barriers and facilitators to optimize trial accrual in oncology settings, highlighting implications for equitable access.
Gill et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: